OM DENNA PODDSÄNDNING 🔗

Uppdateringsfrekvens:
every 44 days
Genomsnittlig ljudlängd:
25 minutes
Gästintervjuer
Har sponsorer
Engelsk
USA
29 avsnitt
sedan 20 februari 2023
episodic

SENASTE AVSNITTET 🔗

Evidence meets practice The expansion of available treatments for migraine led to the development of evidence-based guidelines by the Italian Society for the Study of Headache and the International Headache Society to help guide clinicians in their pharmacologic decision making. Prof. Simona Sacco…

SÖK TIDIGARE AVSNITT

Sök efter tidigare avsnitt från Medicine Matters: The Springer Medicine Podcast.

TIDIGARE AVSNITT

Cracking one of medicine’s newest mysteries VEXAS syndrome is an adult-onset autoinflammatory disorder that was first identified in 2020. Caused by somatic mutations in the UBA1 gene, it can present with a wide spectrum of clinical manifestations. Dr. Peter Grayson, one of the researchers involved…
How does the air we breathe affect cardiovascular health? Around one in five cardiovascular deaths are attributable to environmental stressors, yet these are often overlooked. Air pollution is perhaps the most prevalent, but how does it affect cardiovascular health? Dr. Anusha Seneviratne elaborat…
The next frontier in cancer treatment? Recently there has been a renewed interest in the prospect of therapeutic cancer vaccines. But what exactly does it mean to vaccinate against cancer, where are vaccines showing the most promise, and what are the challenges of making such vaccines a reality? D…
Advancing patient care In this special edition of Medicine Matters , we're joined by Dr Gregory Lim, Claire Greenhill, and Sarah Onuora, Chief Editors of Nature Reviews Cardiology, Endocrinology, and Rheumatology, for a look back at the advances in their specialties in 2025. Find out what caught t…
Clinical recommendations for diagnosis and management Around 10 to 20% of people will complain of dysphagia during their lifetime but uncertainty remains about optimal diagnostic work-up and management. Prof. Edoardo Savarino takes us through the highlights of the updated UEG and ESNM dysphagia gu…
Marking a major milestone in chronic myeloid leukemia treatment Tyrosine kinase inhibitors have transformed the treatment of chronic myeloid leukemia, a condition that had limited therapeutic options before. In this 25th year since the first phase 2 trials of the first TKI, we speak to a researche…
Newcomer PACAP could make the difference in migraine control Anti-CGRP therapy has dramatically improved migraine treatment for many patients since its introduction in 2018. However, 30–40% of patients do not respond adequately to these drugs. Prof. Messoud Ashina talks to us about PACAP and why ta…
Could a world first vaccination program help to prevent the rise of antibiotic resistant cases? Dr. Hamish Mohammed discusses the rollout of the world’s first vaccination program against gonorrhea.
From diabetes to obesity and beyond In 2005 the US FDA approved the first GLP-1 medicine for type 2 diabetes, marking the start of a remarkable journey that goes beyond the stimulation of insulin secretion. Prof. Daniel Drucker gives us a fascinating insight into the early work on GLP-1 and discus…
Ansvarsfriskrivning: Podcasten och konstverket som är inbäddat på den här sidan är från Editorial office Springer Medicine, som är dess ägares egendom och inte anslutet till eller godkänt av Listen Notes, Inc.